APA

Sharabi A., Kim S. S., Kato S., Sanders P. D., Patel S. P., Sanghvi P., Weihe E. & Kurzrock R. (20180316). Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores Cancer Center. : The oncologist.

Chicago

Sharabi Andrew, Kim Sangwoo Shawn, Kato Shumei, Sanders Philip D, Patel Sandip Pravin, Sanghvi Parag, Weihe Elizabeth and Kurzrock Razelle. 20180316. Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores Cancer Center. : The oncologist.

Harvard

Sharabi A., Kim S. S., Kato S., Sanders P. D., Patel S. P., Sanghvi P., Weihe E. and Kurzrock R. (20180316). Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores Cancer Center. : The oncologist.

MLA

Sharabi Andrew, Kim Sangwoo Shawn, Kato Shumei, Sanders Philip D, Patel Sandip Pravin, Sanghvi Parag, Weihe Elizabeth and Kurzrock Razelle. Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores Cancer Center. : The oncologist. 20180316.